Literature DB >> 12530862

6-aza-2'-deoxyisocytidine: synthesis, properties of oligonucleotides, and base-pair stability adjustment of DNA with parallel strand orientation.

Frank Seela1, Yang He.   

Abstract

6-Aza-5-methyl-2'-deoxyisocytidine (1a) and 6-aza-2'-deoxyisocytidine (1b) have been synthesized, converted into phosphoramidite building blocks, and incorporated into oligodeoxynucleotides. The glycosylic bond stability of 1a,b under acidic conditions increases compared to that of 5-methyl-2'-deoxyisocytidine (2a) and 2'-deoxyisocytidine (2b). Oligonucleotides incorporating 1a or 1b show an enhanced stability against the 3'-exonuclease snake-venom phosphodiesterase. The duplexes containing 6-azapyrimidine nucleosides 1a or 1b have lower T(m) values than duplexes containing 2a or 2b with either antiparallel or parallel chain orientation. This was used to adjust the stability of the tridentate m5iCd-dG base pair to the level of the bidentate reverse Watson-Crick dA-dT pair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12530862     DOI: 10.1021/jo020507n

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  2'-deoxy-1-methylpseudocytidine, a stable analog of 2'-deoxy-5-methylisocytidine.

Authors:  Hyo-Joong Kim; Nicole A Leal; Steven A Benner
Journal:  Bioorg Med Chem       Date:  2009-03-27       Impact factor: 3.641

2.  Clamping down on weak terminal base pairs: oligonucleotides with molecular caps as fidelity-enhancing elements at the 5'- and 3'-terminal residues.

Authors:  Sukunath Narayanan; Julia Gall; Clemens Richert
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

3.  Complex self-assembly of pyrimido[4,5-d]pyrimidine nucleoside supramolecular structures.

Authors:  Hang Zhao; Xiurong Guo; Shiliang He; Xin Zeng; Xinglong Zhou; Chaoliang Zhang; Jing Hu; Xiaohua Wu; Zhihua Xing; Liangyin Chu; Yang He; Qianming Chen
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.